| Parexel International Corp | (NQ: PRXL) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | News | Research |
(PRXL) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 25, 2013
(Benzinga,
11/3/10)
Goldman Sachs has published a research report on Parexel International Corporation (NASDAQ: PRXL) after the company reported solid new business win in its 1QFY11.
In the report, Goldman Sachs writes "In addition to slower conversion,...(read more)
(Benzinga,
11/2/10)
Parexel International Corp. (NASDAQ: PRXL) reported adjusted 1QFY11 EPS of $0.30, versus GS/consensus at $0.28 and previous company guidance of $0.27-$0.29, Goldman Sachs reports.
“Relative to our model, revenue in the quarter was...(read more)
(Stock Blog Hub,
4/2/09)
PAREXEL International Corporation (PRXL), which provides consulting services to the drug and medical device industries, reported record service revenue that climbed...(read more)
PAREXEL International (PRXL) Company Overview
There is no analysis for PRXL yet. But you can go to Wikinvest to help create one!
